JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.140, no.1, pp.151-157, 2014 (Peer-Reviewed Journal)
Article / Article
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Science Citation Index Expanded, Scopus
The development of brain metastases (BMs) was associated with poor prognosis in melanoma patients. Patients with BMs have a median survival of < 6 months. Melanoma is the third most common tumor to metastasize to the brain with a reported incidence of 10-40 %. Our aim was to identify factors predicting development of BMs and survival.